These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3846 related articles for article (PubMed ID: 7172404)

  • 1. Pharmacokinetics of dacarbazine (DTIC) and its metabolite 5-aminoimidazole-4-carboxamide (AIC) following different dose schedules.
    Breithaupt H; Dammann A; Aigner K
    Cancer Chemother Pharmacol; 1982; 9(2):103-9. PubMed ID: 7172404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration of dacarbazine pharmacokinetics after interleukin-2 administration in melanoma patients.
    Chabot GG; Flaherty LE; Valdivieso M; Baker LH
    Cancer Chemother Pharmacol; 1990; 27(2):157-60. PubMed ID: 2249333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacokinetics of high-dose DTIC.
    Buesa JM; Urréchaga E
    Cancer Chemother Pharmacol; 1991; 28(6):475-9. PubMed ID: 1934251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of dacarbazine in the regional perfusion of extremities with melanoma.
    Didolkar MS; Jackson AJ; Lesko LJ; Fitzpatrick JL; Buda BS; Johnston GS; Zech LA
    J Surg Oncol; 1996 Nov; 63(3):148-58. PubMed ID: 8944058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous determination of dacarbazine, its photolytic degradation product, 2-azahypoxanthine, and the metabolite 5-aminoimidazole-4-carboxamide in plasma and urine by high-pressure liquid chromatography.
    Fiore D; Jackson AJ; Didolkar MS; Dandu VR
    Antimicrob Agents Chemother; 1985 Jun; 27(6):977-9. PubMed ID: 4026274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absorption, metabolism, and excretion of 14C-temozolomide following oral administration to patients with advanced cancer.
    Baker SD; Wirth M; Statkevich P; Reidenberg P; Alton K; Sartorius SE; Dugan M; Cutler D; Batra V; Grochow LB; Donehower RC; Rowinsky EK
    Clin Cancer Res; 1999 Feb; 5(2):309-17. PubMed ID: 10037179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Penetration of dacarbazine and its active metabolite 5-aminoimidazole-4-carboxamide into cutaneous metastases of human malignant melanoma.
    Joukhadar C; Klein N; Mader RM; Schrolnberger C; Rizovski B; Heere-Ress E; Pehamberger H; Strauchmann N; Jansen B; Müller M
    Cancer; 2001 Oct; 92(8):2190-6. PubMed ID: 11596037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validated hydrophilic interaction LC-MS/MS method for simultaneous quantification of dacarbazine and 5-amino-4-imidazole-carboxamide in human plasma.
    Liu Y; Zhang W; Yang Y
    Talanta; 2008 Oct; 77(1):412-21. PubMed ID: 18804654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of dacarbazine (DTIC) in pregnancy.
    Kantrowitz-Gordon I; Hays K; Kayode O; Kumar AR; Kaplan HG; Reid JM; Safgren SL; Ames MM; Easterling TR; Hebert MF
    Cancer Chemother Pharmacol; 2018 Mar; 81(3):455-460. PubMed ID: 29305638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolated extremity perfusion with DTIC. An experimental and clinical study.
    Aigner K; Hild P; Breithaupt H; Hundeiker M; Schwemmle K; Henneking K; Illig L; Merker G; Paul E; Brodkorb J; Jungbluth A
    Anticancer Res; 1983; 3(2):87-93. PubMed ID: 6682645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of Dacarbazine and Unesbulin and CYP1A2-Mediated Drug Interactions in Patients With Leiomyosarcoma.
    Gao L; Kaushik D; Van Tine BA; Ingham MA; Attia S; Meyer CF; Schwartz GK; Maliakal P; Baird JD; Ma J; Barrett R; D'Silva D; O'Keefe K; Kong R
    Clin Transl Sci; 2023 Dec; 17(2):. PubMed ID: 38129988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemoimmunotherapy of advanced malignant melanoma: sequential administration of subcutaneous interleukin-2 and interferon-alpha after intravenous dacarbazine and carboplatin or intravenous dacarbazine, cisplatin, carmustine and tamoxifen.
    Atzpodien J; Lopez Hänninen E; Kirchner H; Franzke A; Körfer A; Volkenandt M; Duensing S; Schomburg A; Chaitchik S; Poliwoda H
    Eur J Cancer; 1995 Jun; 31A(6):876-81. PubMed ID: 7646914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Polarographic determination of dacarbazine and aminoimidazole carboxamide in human blood and urine].
    Wasilewska L; Deres J
    Acta Pol Pharm; 1981; 38(5):565-71. PubMed ID: 7342697
    [No Abstract]   [Full Text] [Related]  

  • 14. [Chemo-/immunotherapy in advanced malignant melanoma: carboplatin and DTIC or cisplatin, dtic, bcnu and tamoxifen followed by immunotherapy with interleukin 2 and interferon alpha-2a].
    Kirchner HH; Atzpodien J; Poliwoda H
    Med Klin (Munich); 1996 Apr; 91 Suppl 3():44-9. PubMed ID: 8692119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinogenicity of the antineoplastic agent, 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide, and its metabolites in rats.
    Beal DD; Skibba JL; Croft WA; Cohen SM; Bryan GT
    J Natl Cancer Inst; 1975 Apr; 54(4):951-7. PubMed ID: 1127724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled study with imidazole carboxamide (DTIC), DTIC + bacillus Calmette-Guérin (BCG), and DTIC + corynebacterium parvum in advanced malignant melanoma. W.H.O. Collaborating Centres for Evaluation of Methods of Diagnosis and Treatment of Melanoma.
    Tumori; 1984 Feb; 70(1):41-8. PubMed ID: 6369694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicity and complications of vascular isolation and hyperthermic perfusion with imidazole carboxamide (DTIC) in melanoma.
    Didolkar MS; Fitzpatrick JL; Jackson AJ; Johnston GS
    Cancer; 1986 May; 57(10):1961-6. PubMed ID: 3955502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacillus Calmette-Guérin immunotherapy in combination with DTIC (NSC-45388) for the treatment of malignant melanoma.
    Gutterman JU; Mavligit GM; Reed R; Burgess MA; Gottlieb J; Hersh EM
    Cancer Treat Rep; 1976 Feb; 60(2):177-82. PubMed ID: 769970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase I clinical and pharmacological profile of dacarbazine with autologous bone marrow transplantation in patients with solid tumors.
    Adkins DR; Irvin R; Kuhn J; Boldt DH; Roodman GD; Salzman D; Freytes C; Von Hoff DD; LeMaistre CF
    Invest New Drugs; 1993; 11(2-3):169-79. PubMed ID: 8262729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic, biochemical and clinical effects of dimethyltriazenoimidazole-4-carboxamide-bischloroethylnitrosourea combination therapy in patients with advanced breast cancer.
    Clemons M; Ranson M; Margison JM; El Teraifi H; Griffiths A; Kelly J; Morris CQ; Howell A; Margison GP
    Int J Cancer; 2003 Feb; 103(5):686-92. PubMed ID: 12494480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 193.